/BEAM

Beam Therapeutics Inc

BEAM

$23.99USD↓-1.56%-0.38 today

MARKET CAP

2.5B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$24 – $25

52W RANGE

$20

$38

AI Summary

Stalk

TrimMedium

BEAM is exhibiting a Stage 3 distribution phase, marked by a Support Failure breakdown through key horizontal support on elevated volume. Medium-term bias remains bearish, permitting sell-side engagement, while price is extended below declining EMAs and extreme oversold readings caution against immediate selling. Execution is best deferred, stalking for a pullback into the 9/20/50 EMA and prior support zone to sell into stalled rallies. The long-term uptrend remains intact, tempering aggressive downside expectations.

↑Beam 101 Phase 1 trial reports marked HbS induction and total hemoglobin gain.
↑Ends Q2 with $1.15B cash, extending funding runway into mid-2029.
↓EPS forecast cut to $1.25 loss as development costs rise.

Full analysis →

Buying

11

institutions

Selling

6

institutions

New Positions

5

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
FC Farallon Capital Management, L.l.c. Q2 2026	BUYNEW	10.24 M	351.31 M	+10.24 M	+0.0%	1.63%
BI Blackrock, Inc. Q2 2026	BUY	9.00 M	308.80 M	+509.97 K	+52.7%	0.00%
FC Farallon Capital Management LLC Q1 2026	BUY	10.13 M	241.51 M	+71.58 K	-13.4%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	514.77 K	18.14 M	+-36.59 K	+50.2%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	445.00 K	15.27 M	+-68.58 K	+24.8%	0.02%
CA Citadel Advisors LLC Q2 2026	SELL	315.70 K	10.83 M	+-490.37 K	-43.6%	0.00%
EP Eversept Partners, LP Q2 2026	BUYNEW	166.29 K	5.71 M	+166.29 K	+0.0%	0.30%
DF Duquesne Family Office LLC Q2 2026	BUYNEW	153.60 K	5.27 M	+153.60 K	+0.0%	0.10%
MG Man Group Plc Q2 2026	SELL	129.82 K	4.46 M	+-102.17 K	-19.4%	0.01%
JH Janus Henderson Group Plc Q1 2026	BUY	186.51 K	4.44 M	+147.00 K	+306.0%	0.00%
MM Millennium Management LLC Q2 2026	BUY	84.26 K	2.89 M	+62.03 K	+445.8%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	BUYNEW	41.79 K	1.43 M	+41.79 K	+0.0%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	BUYNEW	28.86 K	990.44 K	+28.86 K	+0.0%	0.01%
AC Aqr Capital Management LLC Q2 2026	BUY	19.68 K	675.52 K	+3.99 K	+80.7%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	BUY	4.07 K	139.54 K	+1.53 K	+131.3%	0.00%
AC Adar1 Capital Management, LLC Q2 2026	SELL	0.00	0.00	+-1.45 M	-100.0%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	0.00	0.00	+-25.80 K	-100.0%	0.00%